BBVA USA’s Cardiovascular Systems, Inc. CSII Stock Holding History

BBVA USA’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,000	Closed	-$43K	–	1038
2021 Q2	$43K	Buy	+1,000	New	+$39.1K	﹤0.01%	697

Other funds holding CSII

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BBVA USA's CSII Position: Q3 2021 in Review

BBVA USA sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2021, closing a stake of 1,000 shares — an estimated $43K sold.

BBVA USA first reported a position in CSII in Q2 2021 and held it in 1 quarter. The position peaked at $43K in Q2 2021. 171 funds tracked by Wall St. Rank hold CSII as of Q3 2021.

BBVA USA reported no remaining Cardiovascular Systems, Inc. position as of Q3 2021 after selling out during the quarter.
BBVA USA sold 1,000 Cardiovascular Systems, Inc. shares in Q3 2021, an estimated $43K.
BBVA USA first reported a position in Cardiovascular Systems, Inc. in Q2 2021 and held it in 1 quarter.
BBVA USA's Cardiovascular Systems, Inc. position peaked at $43K in Q2 2021.
171 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.